Results 131 to 140 of about 3,965,960 (305)

Unlocking the potential of cell‐permeable nanobodies for intracellular applications

open access: yesFEBS Letters, EarlyView.
This review outlines current strategies for delivery of nanobodies into cells and highlights recent examples of functional applications. By addressing and manipulating intracellular targets, these molecules hold great potential for treating cancer, respiratory diseases and neurological disorders, making this a vibrant area of research in the biomedical
Mariona Gené‐Verdés   +2 more
wiley   +1 more source

Estimating the Effects of Lenght of Exposure to Traning Program: The Case of Job Corps [PDF]

open access: yes
Length of exposure to a training program is important in determining the labor market outcomes of participants. Employing methods to estimate the causal effects from continuous treatments, we provide insights regarding the effects of different lengths of
Arturo Gonzalez   +3 more
core  

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

open access: yesMolecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Estimating previous exposure to arsenic for populations living in parts of Hungary, Romania and Slovakia [PDF]

open access: yes, 2005
Arsenic Health Risk Assessment and Molecular Epidemiology (ASHRAM) is a large EU-funded case-control study looking at risk of cancer (bladder, kidney and skin) due to arsenic in drinking water.
Hough, RL, Fletcher, T, Leonardi, GS
core   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Radiation Hormesis: Historical Perspective and Implications for Low-Dose Cancer Risk Assessment

open access: yes, 2010
Current guidelines for limiting exposure of humans to ionizing radiation are based on the linear-no-threshold (LNT) hypothesis for radiation carcinogenesis under which cancer risk increases linearly as the radiation dose increases.
Alexander M. Vaiserman   +1 more
core   +1 more source

Analysis of Current Industry Practices for Informing Dosing Recommendation for Patients With Renal Impairment

open access: yesClinical and Translational Science
Recent updates in clinical guidelines and health authority guidance documents have aimed to standardize best practices for assessing renal function; however, it remains unclear whether the pharmaceutical industry has fully adopted these recommendations ...
Noah Christopher Frazier   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy